People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with ...

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex ...

Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

While there's no cure for wet age-related macular degeneration (AMD), there are ways to slow the disease and help you see better for longer. But early detection and timely treatment hold the key to ...

The burdens that monthly or every-other-month injections in the eye impose on patients with retinal diseases are well-known to be barriers to care for many people with these conditions. Making ...

A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness.

A whisper-thin chip, smart glasses and patient training are reshaping how older people live with central vision loss across ...

Age-Related Macular Degeneration (AMD) is the biggest cause of sight loss in the UK, affecting around 700,000 people. As February is AMD Awareness Month, Optegra Eye Clinic West London is spotlighting ...

The AMD pipeline presents opportunities via emerging novel therapies focusing on innovative mechanisms such as gene therapy, mitochondria-targeting peptides, and complement inhibition. Key drugs in ...